New cholesterol Drug's safety check: will it interfere with other meds?

NCT ID NCT07608705

Recruiting now Knowledge-focused Sponsor: Shandong Suncadia Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial in 16 healthy adults tests whether a new drug for high cholesterol, HRS-1301, changes how the body processes two common medicines: midazolam (a sedative) and atorvastatin (a cholesterol drug). Participants will take these drugs alone and together with HRS-1301, and researchers will measure drug levels in the blood. The goal is to understand potential drug interactions before testing HRS-1301 in patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HRS-1301 tablets
What this could lead to: If successful, this study will show whether HRS-1301 changes how the body processes other drugs, helping guide safe use in future patients.
What could go wrong: This is a very early, small study in healthy people, not patients. It only looks at drug levels, not whether HRS-1301 works for high cholesterol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERLIPIDEMIAS

Contacts and locations

Locations

Qilu Hospital of Shandong University
RECRUITING

Jinan, Shandong, 250012, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.